For research use only. Not for therapeutic Use.
AT-101 acetic acid (CAT: I005214) is the R-(-) enantiomer of gossypol acetic acid. It exhibits binding affinity to Bcl-2, Bcl-xL, and Mcl-1 with Ki values of 0.32 μM, 0.48 μM, and 0.18 μM, respectively. AT-101 is an orally bioavailable BH3 mimetic that interacts with the hydrophobic surface binding groove BH3 of anti-apoptotic proteins, inhibiting their heterodimerization with pro-apoptotic members of the Bcl-2 family. By doing so, it can impede tumor cell proliferation and induce apoptosis. In vitro, studies have shown that AT-101 activates caspase-9 and induces apoptosis in various cancer cell lines, including drug-resistant and multiple myeloma cells. In vivo, AT-101 delays the onset of androgen-independent growth in VCaP prostate cancer xenografts.
Catalog Number | I005214 |
CAS Number | 866541-93-7 |
Molecular Formula | C30H30O8.C2H4O2 |
Purity | ≥95% |
Target | Bcl-2 Family; Autophagy |
Solubility | DMSO; Methanol: ≤ 7.75 mg/mL |
Storage | 3 years -20C powder |
IC50 | 0.32/0.48/0.18 uM for Bcl-2/Bcl-xL/Mcl-1 |
Reference | <p style=/line-height:25px/> |